Portnoy David's Form 4 filing
Cryo Cell International Inc (CCEL) · filed Nov 21, 2022
- Accession no.
- 0001209191-22-058194
- Filed
- Nov 21, 2022
- Trade date
- Nov 17-18, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.14K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Portnoy DavidCIK 0001315416 | Director, Officer (Chairman, Co-CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Common Stock | PPurchaseAcquired | +516 | $4.90 | +$2,528.4 | 230,087 | Indirect | |
| Nov 18, 2022 | Common Stock | PPurchaseAcquired | +532 | $4.90 | +$2,606.8 | 230,619 | Indirect | |
| Nov 18, 2022 | Common Stock | PPurchaseAcquired | +2 | $4.86 | +$9.72 | 230,621 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.